I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Efficacy, Safety of Baricitinib plus Remdesivir versus Stan..:
Khin Phyu Pyar
;
Sai Aik Hla
;
Aung Phyoe Kyaw
...
doi:10.5281/zenodo.6386399. , 2022
Link:
https://zenodo.org/record/6386400
RT Journal T1
Efficacy, Safety of Baricitinib plus Remdesivir versus Standard Therapy (Remdesivir) in Patients with Severe COVID-19 Infection in Third Wave of Epidemics in Myanmar: Case Control Study
UL https://suche.suub.uni-bremen.de/peid=base-ftzenodo:oai:zenodo.org:6386400&Exemplar=1&LAN=DE A1 Khin Phyu Pyar A1 Sai Aik Hla A1 Aung Phyoe Kyaw A1 Nyan Lin Maung A1 Zar Ni Htet Aung A1 Thi Han Tun A1 Min Aung Shan A1 Yan Lin Aung A1 Kyaw Zaw Lin A1 Si Phyo Thu A1 Thu Htoo Kyaw A1 Kyaw Zay Ya A1 Myo Thant Kyaw A1 Zay Phyo Aung A1 Than Tun Aung A1 Aung Thit A1 Aung Hlaing Win A1 Myo Min Thu A1 Thurein Wynn A1 Han Lin Aung A1 Lynn Htet Aung A1 Lay Maung Maung A1 Ye Min Hein A1 Moe Tun Zaw A1 Myo Maung Maung A1 Myo Min Thant YR 2022 K1 Baricitinib K1 Standard treatment K1 Remdesivir K1 severe COVID-19 infection K1 survival JF doi:10.5281/zenodo.6386399 LK http://dx.doi.org/https://zenodo.org/record/6386400 DO https://zenodo.org/record/6386400 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)